Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dipyridamole Effects on Innate Immune Response in Human Endotoxemia
NCT01091571Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2010
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dipyridamole in sepsis, septic shock, sponsored by Radboud University Medical Center. Started Mar 2010; status: completed.
02
Drugs
dipyridamole
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT01091571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01091571.